Detalles de la búsqueda
1.
Comparison of the reactogenicity and immunogenicity between two-dose mRNA COVID-19 vaccine and inactivated COVID-19 vaccine followed by an mRNA vaccine in children aged 5-11 years.
J Med Virol
; 95(5): e28758, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37212319
2.
Molecular characterisation and tracking of severe acute respiratory syndrome coronavirus 2 in Thailand, 2020-2022.
Arch Virol
; 168(1): 26, 2023 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36593392
3.
Neutralizing Activities Against the Omicron Variant After a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination.
J Infect Dis
; 226(8): 1372-1381, 2022 10 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35267040
4.
Safety and immunogenicity of inactivated COVID-19 vaccine in health care workers.
J Med Virol
; 94(4): 1442-1449, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34783049
5.
Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
Virol J
; 18(1): 52, 2021 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33750394
6.
Breakthrough Infection by SARS-CoV-2 Delta and Omicron Variants Elicited Immune Response Comparable to mRNA Booster Vaccination.
J Infect Dis
; 226(6): 1122-1124, 2022 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35789392
7.
Asymptomatic and sub-microscopic malaria infection in Kayah State, eastern Myanmar.
Malar J
; 16(1): 138, 2017 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28376883
8.
Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 Infection.
Vaccines (Basel)
; 12(2)2024 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38400163
9.
Evaluation of Anti-S1 IgA Response to Different COVID-19 Vaccination Regimens.
Vaccines (Basel)
; 11(6)2023 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37376506
10.
Real-World Study: Hybrid Immunity against SARS-CoV-2 Influences the Antibody Levels and Persistency Lasting More than One Year.
Vaccines (Basel)
; 11(11)2023 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38006025
11.
Investigation of the Molecular Epidemiology and Evolution of Circulating Severe Acute Respiratory Syndrome Coronavirus 2 in Thailand from 2020 to 2022 via Next-Generation Sequencing.
Viruses
; 15(6)2023 06 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37376693
12.
Seroprevalence of anti-SARS-CoV-2 antibodies and associated factors among household contacts of COVID-19 confirmed cases in Bangkok, Thailand.
Heliyon
; 9(5): e16501, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37251836
13.
The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5.
Vaccines (Basel)
; 11(3)2023 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36992154
14.
SARS-CoV-2 Antibody Dynamics after COVID-19 Vaccination and Infection: A Real-World Cross-Sectional Analysis.
Vaccines (Basel)
; 11(7)2023 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37515001
15.
Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (CovovaxTM) after homologous and heterologous two-dose regimens.
Int J Infect Dis
; 126: 64-72, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36427701
16.
Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: a cross-sectional survey from October 2022 to January 2023.
Sci Rep
; 13(1): 15595, 2023 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37730917
17.
Evolutionary and Genetic Recombination Analyses of Coxsackievirus A6 Variants Associated with Hand, Foot, and Mouth Disease Outbreaks in Thailand between 2019 and 2022.
Viruses
; 15(1)2022 12 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36680113
18.
Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: Real-world data.
Vaccine
; 40(23): 3203-3209, 2022 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35465981
19.
Vaccine-Related adverse events following AZD1222 (ChAdOx1-nCoV-19) Covid-19 vaccine in solid malignancy patients receiving cancer treatment, as compared to age-matched healthy controls.
Hum Vaccin Immunother
; 18(6): 2094149, 2022 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35776836
20.
Strong Correlations between the Binding Antibodies against Wild-Type and Neutralizing Antibodies against Omicron BA.1 and BA.2 Variants of SARS-CoV-2 in Individuals Following Booster (Third-Dose) Vaccination.
Diagnostics (Basel)
; 12(8)2022 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35892491